Khandelwal Hospital And Urology Centre Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -4.73%
- Profit Growth -48.69%
- Ebitda -21.06%
- Net Worth 11.56%
- Total Assets 17.38%
About Khandelwal Hospital And Urology Centre
Khandelwal Hospital And Urology Centre Private Limited (KHAUCPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 May 2017 (Seven years and nine months 2 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Vivek Khandelwal and Reena Khandelwal serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74999DL2017PTC318246
- Company No.
318246
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 May 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Khandelwal Hospital And Urology Centre?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vivek Khandelwal  | Director | 26-May-2017 | Current |
| Reena Khandelwal | Director | 26-May-2017 | Current |
Financial Performance of Khandelwal Hospital And Urology Centre.
Khandelwal Hospital And Urology Centre Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.73% decrease. The company also saw a substantial fall in profitability, with a 48.69% decrease in profit. The company's net worth Soared by an impressive increase of 11.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Khandelwal Hospital And Urology Centre?
Unlock access to Khandelwal Hospital And Urology Centre's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Corona Pharmaceuticals Private Limited.Vivek Khandelwal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Khandelwal Hospital And Urology Centre?
Khandelwal Hospital And Urology Centre has a workforce of 29 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Khandelwal Hospital And Urology Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Khandelwal Hospital And Urology Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.